Why is Caribou Biosciences Stock (CRBU) Down 43% Today?
Shares in Caribou Biosciences ($CRBU) plunged over 43% today as investors reacted to the company’s decision to potentially put itself up for sale a...
Caribou Biosciences Inc. (CRBU)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 2,773,545 | $4,881,439 | +8% | 0.01% |
| 2. | Kynam Capital Derrick Tang | 2,503,302 | $4,405,812 | 0.24% | |
| 3. | Maverick Capital Lee Ainslie | 652,542 | $1,148,474 | 0.01% | |
| 4. | 72 Investment Holdings Steve Cohen | 474,067 | $834,358 | 1.67% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 375,686 | $661,205 | -69% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.02 | 20,000 | $20,400.00 | 3,369,395 | 2025-03-14 | Filing | |
| $1.42 | 17,360 | $24,651.20 | 17,360 | 2025-01-29 | Filing | |
| $4.11 | 6,818 | $28,021.98 | 109,082 | 2022-01-11 | Filing | |
| $2.69 | 569 | $1,530.61 | 102,264 | 2022-01-11 | Filing | |
| $2.69 | 1,136 | $3,055.84 | 101,695 | 2021-12-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.93 | 6,228 | $12,020.04 | 73,125 | 2026-02-25 | Filing | |
| $1.96 | 3,147 | $6,168.12 | 79,353 | 2026-02-24 | Filing | |
| $1.96 | 6,938 | $13,598.48 | 481,564 | 2026-02-24 | Filing | |
| $1.96 | 6,938 | $13,598.48 | 104,998 | 2026-02-24 | Filing | |
| $1.96 | 1,066 | $2,089.36 | 68,523 | 2026-02-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 551,445 | $700,335 | 0.47% | |
| 2. | 202,703 | $257,433 | 0.04% | |
| 3. | 32,000 | $40,640 | 0.01% | |
| 4. | 13,231 | $16,803 | 0% | |
| 5. | 7,397 | $9,394 | 0% |
News See All
8 Best Up and Coming Penny Stocks to Buy Now
In this article, we will discuss 8 Best Up and Coming Penny Stocks to Buy Now. Penny stocks occupy one of the most debated and polarizing segments of the financial markets.
Caribou Biosciences (CRBU)’s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street
Caribou Biosciences, Inc. (NASDAQ:CRBU) is included in our list of the 7 most volatile stocks under $5 for day trading.
7 Most Volatile Stocks Under $5 for Day Trading
In this piece, we discuss the 11 Most Volatile Stocks Under $5 for Day Trading. Morningstar released its Q1 2026 U.S. Stock Market Outlook report last month. Led by Chief U.S.
Top 11 CRISPR Stocks to Invest In
In this article, we will take a look at the Top 11 CRISPR Stocks to Invest in.
5 $10 Stocks That Will Triple
In this article, we discuss 5 $10 stocks that will triple. If you want to read our discussion on the latest stock market landscape, head directly to 12 $10 Stocks That Will Triple. 5.
These 5 Stocks Under $10 Are Poised To Explode
In this piece, we will take a look at these 5 stocks under $10 are poised to explode. If you want to read our introduction to these tricky stocks, jump to These Stocks under $10 Are Poised To Explode.
12 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 12 gene editing stocks with the best long-term potential.
10 Best Gene Editing Stocks To Buy
In this article, we discuss 10 best gene editing stocks to buy. A report by The Wall Street Journal dated September 16 suggests that Intellia Therapeutics, Inc.
9 Healthcare Stocks to Invest In Today According to Stanley Druckenmiller
In this piece, we will take a look at the nine healthcare stocks to invest in today according to Stanley Druckenmiller.
Hedge Fund Resource Center